A breakthrough drug for ovarian cancer that is kinder on the body and extends lives is now available on the NHS. The drug, called mirvetuximab soravtansine, is a known as a "biological missile" as it delivers chemotherapy drugs direct to the cancerous tissue rather than to the whole body. Patricia Hill said the treatment was allowing her to do things like visiting family and going to the theatre, that were impossible on conventional chemotherapy. Up to 400 patients a year in England could benefit from the new treatment, the first for hard-to-treat ovarian cancer in 20 years. Tap the link in BBCNews's bio to read more about the new drug. (📸 Patricia Hill) #Ovariancancer #Cancer #NHS #England #BBCNews